Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
作者信息
Lallas A, Moscarella E, Kittler H, Longo C, Thomas L, Zalaudek I, Kyrgidis A, Manoli S M, di Meo N, Papageorgiou C, Apalla Z, Argenziano G
机构信息
First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
DERMOMEDICA Dermatology Unit, Thessaloniki, Greece.
出版信息
Br J Dermatol. 2021 Sep;185(3):675-677. doi: 10.1111/bjd.20407. Epub 2021 Jul 5.
PMID:33894006
Abstract
摘要
Zotero 插件